Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple subcutaneous administrations.

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple subcutaneous administrations.

Item
http://www.wikidata.org/entity/Q37466936
A biomathematical model of human erythropoiesis under erythropoietin and chemotherapy administration.Population pharmacokinetic and pharmacodynamic model-based comparability assessment of a recombinant human Epoetin Alfa and the Biosimilar HX575.Quantitative assessment of minimal effective concentration of erythropoiesis-stimulating agents.Clinical trials for authorized biosimilars in the European Union: a systematic review.Colony stimulating factors (CSF) biosimilars. Progress?Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments.Clinical safety of biosimilar recombinant human erythropoietins.State-of-the-art biosimilar erythropoietins in the management of renal anemia: lessons learned from Europe and implications for US nephrologists.Use of biosimilar epoetin to increase hemoglobin levels in patients with chemotherapy-induced anemia: real-life clinical experience.Comparison of the pharmacokinetic and pharmacodynamic profiles of one US-marketed and two European-marketed epoetin alfas: a randomized prospective study.Comparable pharmacokinetics and pharmacodynamics of two epoetin alfa formulations Eporon® and Eprex® following a single subcutaneous administration in healthy male volunteers.HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience.Development and 10-year history of a biosimilar: the example of Binocrit®.
P2860

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple subcutaneous administrations.

Item
http://www.wikidata.org/entity/Q37466936
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bioequivalence of HX575 (recom ...... subcutaneous administrations.
@en
Bioequivalence of HX575
@nl
type
label
Bioequivalence of HX575 (recom ...... subcutaneous administrations.
@en
Bioequivalence of HX575
@nl
prefLabel
Bioequivalence of HX575 (recom ...... subcutaneous administrations.
@en
Bioequivalence of HX575
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Bioequivalence of HX575 (recom ...... subcutaneous administrations.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932